Price Hikes for Hundreds of Medications
US drug companies have started the new year by raising the prices of hundreds of medications.
US drug companies have started the new year by raising the prices of hundreds of medications.
A recent survey of US-based opioid treatment programs (OTPs) suggests that many programs should increase the use of methadone, buprenorphine, and extended-release naltrexone in treating opioid use disorder (OUD).
Retail prescription drug prices in the United States fell by 1% last year, a new government report shows.
The United States routinely outspends other high-income countries on prescription drugs because of the lack of price controls or negotiation by government health care systems.
Levetiracetam, fosphenytoin, and valproate are equally effective in children and adults for the treatment of benzodiazepine-refractory convulsive status epilepticus.
The Food and Drug Administration (FDA) has approved Trikafta (elexacaftor/tezacaftor/ivacaftor; Vertex) for the treatment of patients aged 12 years and older with cystic fibrosis (CF) who have ≥1 F508del mutation in the cystic fibrosis transmembrane conductance regulator (CFTR) gene. Trikafta is a fixed-dose combination containing elexacaftor 100mg, tezacaftor 50mg, and ivacaftor 75mg that is co-packaged…
Free distribution of essential medicines was shown to improve treatment adherence. Bettering access to essential medicines can improve quality of care and move toward achieving univer-sal health coverage.
Some lots of losartan have been found to be contaminated with the cancer-causing chemical N-methylnitrosobutyric acid.
The proposed plan would allow Medicare to negotiate prices for high-cost drugs.
Preliminary tests found low levels of N-nitrosodimethylamine in some ranitidine products.